rss
Ann Rheum Dis 2007;66:1249-1251 doi:10.1136/ard.2007.071621
  • Concise report

Contribution of anti-cyclic citrullinated peptide antibody and rheumatoid factor to the diagnosis of arthropathy in haemochromatosis

  1. E Aigner1,
  2. I Schmid2,
  3. C H Österreicher3,
  4. J Zwerina6,
  5. G Schett6,
  6. M Strasser4,
  7. F Niksic1,
  8. F Hohla1,
  9. T Ramsauer5,
  10. U Dorn5,
  11. W Patsch2,
  12. C Datz1
  1. 1Department of Internal Medicine, General Hospital Oberndorf, Teaching Hospital of the Paracelsus Medical University Salzburg, Oberndorf, Austria
  2. 2Department of Labaratory Medicine, Paracelsus Medical University Salzburg, Salzburg, Austria
  3. 3Department of Medicine, Columbia University, New York
  4. 4Department of Medicine, Paracelsus Medical University Salzburg, Salzburg, Austria
  5. 5Department of Orthopedic Surgery, Paracelsus Medical University Salzburg, Salzburg, Austria
  6. 6Third Department of Medicine, Medical University of Erlangen, Erlangen, Germany
  1. Correspondence to:
    Christian Datz
    MD, Associate Professor for Internal Medicine, Hospital Oberndorf, Teaching Hospital of the Paracelsus Medical University Salzburg, Paracelsusstrasse 37, 5110 Oberndorf; c.datz{at}kh-obdf.salzburg.at
  • Accepted 14 April 2007
  • Published Online First 24 April 2007

Abstract

Objective: To investigate the prevalence of antibodies to cyclic citrullinated peptide (anti-CCP) and rheumatoid factor in patients with hereditary haemochromatosis (HHC) and to evaluate their diagnostic reliability in distinguishing HHC-associated arthropathy from rheumatoid arthritis.

Methods: Anti-CCP antibodies and rheumatoid factor levels were determined by ELISA in sera from 87 patients with HHC homozygous for the C282Y mutation of the HFE gene, 31 patients with rheumatoid arthritis and 162 healthy controls.

Results: Of the 87 patients with HHC, 32 (36.8%) had joint involvement. Anti-CCP antibodies were detected in only 1 patient (1.1%) with HHC, who had no joint disease, and in (1.2%) healthy controls. In total, 18 (58.1%) patients with rheumatoid arthritis displayed anti-CCP reactivity (p<0.001). Rheumatoid factor was detected in 10 (11.5%) patients with HHC compared with 7 (4.3%) healthy control subjects (p = 0.03) and 21 of 31 (65.6%) patients with rheumatoid arthritis.

Conclusions: Testing for anti-CCP antibodies discriminates HHC arthropathy from rheumatoid arthritis, as these patients were consistently anti-CCP negative. Thus, HHC arthropathy should be considered in the differential diagnosis of CCP-negative arthritis.

Footnotes

  • Published Online First 19 April 2007

This Article

  1. Abstract
  2. Full text
  3. PDF
  4. All versions of this article:
    1. ard.2007.071621v1
    2. 66/9/1249 most recent

Responses

  1. Submit a response
  2. No responses published

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.